Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this condition.
The report details the trend, potential and market size of Tysabri Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tysabri Drugsmarket, defines the market attractiveness level of Tysabri Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tysabri Drugs industry, describes the types of Tysabri Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tysabri Drugs market and the development prospects and opportunities of Tysabri Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tysabri Drugs market in Chapter 13.
By Player:
Biogen
By Type:
Multiple Sclerosis
Crohn's Disease
By End-User:
Hospital
Drugs Stores
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tysabri Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tysabri Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tysabri Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tysabri Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tysabri Drugs Market Analysis and Outlook to 2022
-
7.1 Global Tysabri Drugs Consumption (2017-2022)
-
7.2 United States Tysabri Drugs Consumption (2017-2022)
-
7.3 Europe Tysabri Drugs Consumption (2017-2022)
-
7.4 China Tysabri Drugs Consumption (2017-2022)
-
7.5 Japan Tysabri Drugs Consumption (2017-2022)
-
7.6 India Tysabri Drugs Consumption (2017-2022)
-
7.7 South Korea Tysabri Drugs Consumption (2017-2022)
8 Region and Country-wise Tysabri Drugs Market Analysis and Outlook to 2028
-
8.1 Global Tysabri Drugs Consumption Forecast (2022-2028)
-
8.2 United States Tysabri Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Tysabri Drugs Consumption Forecast (2022-2028)
-
8.4 China Tysabri Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Tysabri Drugs Consumption Forecast (2022-2028)
-
8.6 India Tysabri Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Tysabri Drugs Consumption Forecast (2022-2028)
9 Global Tysabri Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Tysabri Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
9.2 Global Tysabri Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Stores Consumption and Growth Rate (2017-2022)
10 Global Tysabri Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Tysabri Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tysabri Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
11 Global Tysabri Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tysabri Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tysabri Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tysabri Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tysabri Drugs Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Tysabri Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Tysabri Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tysabri Drugs
-
Figure Tysabri Drugs Picture
-
Table Global Tysabri Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tysabri Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tysabri Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tysabri Drugs Consumption by Country (2017-2022)
-
Figure United States Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tysabri Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Tysabri Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tysabri Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tysabri Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tysabri Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Tysabri Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Tysabri Drugs Product and Service
-
